Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 256

Results For "IMI"

3840 News Found

Lupin partners global Agencies to support tuberculosis prevention treatment
News | October 09, 2022

Lupin partners global Agencies to support tuberculosis prevention treatment

Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price


Nureca's subsidiary receives ISO 13485 certification for Indian medical device facility
Medical Device | October 09, 2022

Nureca's subsidiary receives ISO 13485 certification for Indian medical device facility

The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries


Thermo Fisher Scientific emphasizes on the need for more disruptive technologies
Medical Device | October 09, 2022

Thermo Fisher Scientific emphasizes on the need for more disruptive technologies

Thermo Fisher is working closely with large pharmaceutical businesses to develop companion diagnostics in multiple areas such as heart disease, neurosciences and infectious diseases.


BioMarin simplifies organizational structure to increase efficiency
News | October 09, 2022

BioMarin simplifies organizational structure to increase efficiency

The reduction in force will result in financial savings of approximately $50 million annually beginning in 2023


ICON selected by BARDA to conduct anthrax vaccine clinical trial
Diagnostic Center | October 09, 2022

ICON selected by BARDA to conduct anthrax vaccine clinical trial

This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.


Glenmark launches Lobeglitazone in India for Uncontrolled Type 2 Diabetes in adults
News | October 07, 2022

Glenmark launches Lobeglitazone in India for Uncontrolled Type 2 Diabetes in adults

Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).


Presss note on WHO Medical product alert regarding Maiden Pharmaceuticals
News | October 07, 2022

Presss note on WHO Medical product alert regarding Maiden Pharmaceuticals

DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.


Zydus receives final approval from USFDA and 180 days shared exclusivity for Brivaracetam Tablets
Drug Approval | October 07, 2022

Zydus receives final approval from USFDA and 180 days shared exclusivity for Brivaracetam Tablets

Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.


Lupin appoints Dr. Shahin Fesharaki as Global Chief Scientific Officer
People | October 07, 2022

Lupin appoints Dr. Shahin Fesharaki as Global Chief Scientific Officer

Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.


Granules India inaugurated water tank at Bonthapally village
News | October 05, 2022

Granules India inaugurated water tank at Bonthapally village

The two overhead tanks commissioned at a cost of Rs 57 lakh will be maintained by the village panchayats.